pre14a
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No. )
|
|
|
Filed by the Registrant
þ |
|
Filed by a Party other than the Registrant o |
|
|
Check the appropriate box: |
|
|
|
þ Preliminary Proxy Statement |
|
o
Confidential, for Use of the Commission Only (as permitted by
Rule 14a-6(e)(2)) |
|
o Definitive Proxy Statement |
|
o Definitive Additional Materials |
|
o
Soliciting Material Pursuant to §240.14a-12 |
ZIMMER HOLDINGS, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy
Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|
|
|
þ No fee required. |
|
o
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and
0-11. |
|
|
|
1) Title of each class of securities to which transaction applies: |
|
|
|
2) Aggregate number of securities to which transaction applies: |
|
|
|
3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined): |
|
|
|
4) Proposed maximum aggregate value of transaction: |
|
|
|
o Fee paid previously with preliminary materials. |
|
|
|
o Check box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee
was paid previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its filing. |
|
|
|
1) Amount Previously Paid: |
|
|
|
2) Form, Schedule or Registration Statement No.: |
|
|
SEC 1913 (02-02) |
Persons who potentially are to respond to the collection of information
contained in this form are not required to respond unless the form displays a currently valid
OMB control number. |
ZIMMER HOLDINGS, INC.
345 East Main Street
Warsaw, Indiana 46580
March , 2007
Dear Fellow Stockholder:
You are cordially invited to attend the 2007 Annual Meeting of
Stockholders of Zimmer Holdings, Inc., which will be held at
9:00 a.m. on Monday, May 7, 2007, at The New York
Palace Hotel, 455 Madison Avenue, New York, New York.
This booklet includes a notice of meeting and proxy statement.
The proxy statement describes the business to be conducted at
the meeting and provides other information that you should know
when you vote your shares. Following the required business
meeting we will report on the companys operations.
It is important that your shares be represented whether or not
you attend the meeting. Registered stockholders can vote their
shares via the Internet or by using a toll-free telephone
number. Instructions for using these convenient services appear
on the proxy card. You can also vote your shares by marking your
votes on the proxy card, signing and dating it and mailing it
promptly using the envelope provided.
We have provided space on the proxy card for comments. We urge
you to use it to let us know your feelings about the company or
to bring a particular matter to our attention. If you hold your
shares through an intermediary, please feel free to write
directly to us.
|
|
|
 |
|
|
J. Raymond Elliott |
|
Chairman, President and Chief Executive Officer |
TABLE OF CONTENTS
Zimmer Holdings, Inc.
345 East Main Street
Warsaw, Indiana 46580
NOTICE OF ANNUAL MEETING
OF STOCKHOLDERS
|
|
|
TIME AND DATE |
|
9:00 a.m., Eastern Time, on Monday, May 7, 2007 |
|
PLACE |
|
The New York Palace Hotel
455 Madison Avenue
New York, New York |
|
ITEMS OF BUSINESS |
|
(1) To elect two members of the Board of Directors
for three-year terms. |
|
|
|
(2) To ratify the appointment of
PricewaterhouseCoopers LLP as our independent registered public
accounting firm for 2007. |
|
|
|
(3) To approve amendments to our Restated Certificate
of Incorporation to require the annual election of all directors. |
|
|
|
(4) To consider and vote on a stockholder proposal. |
|
|
|
(5) To transact such other business as may properly
come before the meeting and any adjournment or postponement. |
|
RECORD DATE |
|
You can vote if you are a stockholder of record on March 8,
2007. |
|
ANNUAL REPORT |
|
Our 2006 Annual Report, which is not a part of the proxy
solicitation material, is enclosed. |
|
PROXY VOTING |
|
Your vote is important, regardless of the number of shares you
own. If you do not attend the meeting to vote in person, your
vote will not be counted unless a proxy representing your shares
is presented at the meeting. To ensure that your shares will be
voted at the meeting, please vote in one of these ways: |
|
|
|
(1) Go to the website shown on your proxy card and
vote via the Internet; |
|
|
|
(2) Use the telephone number shown on your proxy card
(this call is toll-free in the United States); or |
|
|
|
(3) Mark, sign, date and promptly return the enclosed
proxy card in the postage-paid envelope. |
|
|
|
If you do attend the meeting, you may revoke your proxy and vote
by ballot. |
|
|
|
By Order of the Board of Directors |
|
|
 |
|
|
Chad F. Phipps |
|
Associate General Counsel and Corporate Secretary |
March , 2007
|
|
ZIMMER HOLDINGS, INC. |
2007 PROXY STATEMENT |
ZIMMER HOLDINGS, INC.
PROXY STATEMENT
ANNUAL MEETING AND VOTING INFORMATION
Why did I receive these proxy materials?
You are receiving these proxy materials in connection with the
solicitation of proxies on behalf of the Board of Directors of
Zimmer Holdings, Inc. (Zimmer, we,
us, our or the company) for
use at the Annual Meeting of Stockholders on May 7, 2007.
We are sending this proxy statement to all stockholders of
record as of the close of business on March 8, 2007 for
delivery beginning March , 2007.
Who is entitled to vote at the annual meeting?
Holders of record of our $0.01 par value common stock at
the close of business on March 8, 2007 will be entitled to
vote at the meeting. As of that date, there
were shares
of common stock outstanding and entitled to vote. We are
soliciting proxies on behalf of the Board of Directors to give
all stockholders who are entitled to vote on the matters that
come before the meeting the opportunity to do so whether or not
they attend the meeting in person.
What will stockholders vote on at the meeting?
Four items:
|
|
|
|
|
election of directors |
|
|
|
ratification of the appointment of our independent registered
public accounting firm |
|
|
|
a management proposal to amend our Restated Certificate of
Incorporation to require the annual election of all directors |
|
|
|
a stockholder proposal for simple majority voting |
Will there be any other items of business on the agenda?
We do not expect any other items of business because the
deadline for stockholder proposals and nominations has already
passed. Nonetheless, in case there is an unforeseen need, the
accompanying proxy gives discretionary authority to the persons
named on the proxy with respect to any other matters that might
be brought before the meeting. Those persons intend to vote that
proxy in accordance with their best judgment.
What are the recommendations of the Board of Directors on how
I should vote my shares?
The Board of Directors recommends that you vote your shares as
follows:
|
|
|
|
|
FOR the election of the two nominees as
directors; |
|
|
|
FOR ratification of the appointment of our
independent registered public accounting firm; |
|
|
|
FOR approval of amendments to our Restated
Certificate of Incorporation to require the annual election of
all directors; and |
|
|
|
AGAINST the stockholder proposal for
simple majority voting. |
|
|
ZIMMER HOLDINGS, INC. |
2007 PROXY STATEMENT |
What is the difference between a stockholder of
record and a beneficial holder?
These terms describe how your shares are held. If your shares
are registered directly in your name with The Bank of New York,
our transfer agent, you are a stockholder of record.
If your shares are held in the name of a bank, broker, trust or
other nominee as custodian, you are a beneficial
holder.
What are my voting rights?
Holders of our common stock are entitled to one vote per share.
How do I vote by proxy?
If you are a stockholder of record, we encourage you to vote via
the Internet or by telephone. Internet and telephone voting
information is provided on the proxy card. These methods are
convenient and save us significant postage and processing
expense. In addition, when you vote via the Internet or by
telephone prior to the meeting date, your vote is recorded
immediately and there is no risk that postal delays will cause
your vote to arrive late and therefore not be counted.
If you choose to vote by mail, mark your proxy card, date and
sign it, and mail it in the postage-paid envelope. The shares
represented will be voted according to your directions. If your
proxy card is signed and returned without specifying a vote or
an abstention on any proposal, it will be voted according to the
recommendation of the Board of Directors on that proposal.
If you are a beneficial holder, you must provide instructions on
voting to your bank, broker, trust or other nominee holder.
How do I vote in person?
If you are a stockholder of record, you may vote your shares in
person at the meeting. However, we encourage you to vote by
proxy card, by telephone, or on the Internet even if you plan to
attend the meeting. If you are a beneficial holder and wish to
vote in person at the meeting, you must obtain from your bank,
broker, trust or other nominee holder a legal proxy issued in
your name and present it to the inspectors of election with your
ballot to be able to vote at the meeting.
How do I vote my shares in the 401(k) plan?
If you participate in the Zimmer Holdings, Inc. Savings and
Investment Program or the Zimmer Puerto Rico Savings and
Investment Program, you may instruct the plan trustee on how to
vote your shares by mail, by telephone or via the Internet as
described above. Your plan trustee will vote the shares credited
to your plan account in accordance with your voting
instructions. The trustee votes the shares on your behalf
because you are the beneficial holder, not the record holder, of
the shares credited to your account. The trustee will vote the
plan shares for which it does not receive voting instructions in
the same proportion as the shares for which it received voting
instructions.
What can I do if I change my mind after I vote my shares?
If you are a stockholder of record, you may revoke your proxy at
any time before it is voted at the meeting by: (1) giving
timely written notice of the revocation to our Corporate
Secretary; or (2) submitting a later-dated vote in person
at the meeting, via the Internet, by telephone or by mail. If
you are a beneficial holder, you may submit new voting
instructions by contacting your bank, broker, trust or other
nominee holder. You may also vote in person at the annual
meeting if you obtain a legal proxy as described above.
What vote is required to approve each proposal?
Directors receiving the majority of votes cast (where the number
of shares voted for a director exceeds the number of
shares voted against the director) will be elected,
provided that if the number of nominees exceeds the number of
directors to be elected (a situation we do not anticipate), the
directors will be elected by a plurality of the votes cast.
Ratification of the selection of our independent registered
public accounting firm and approval of the stockholder proposal
will each require the affirmative vote of the majority of the
shares of common stock present or represented by proxy. Approval
of the proposed amendments to our Restated Certificate of
Incorporation will require the affirmative vote of 80% of the
outstanding shares of common stock.
What effect do abstentions and broker non-votes have?
Shares not present at the meeting and shares voting
abstain have no effect on the election of directors.
For the proposal to ratify the selection of our independent
registered public accounting firm, the proposal to approve
amendments to our Restated Certificate of Incorporation and the
stockholder proposal, abstentions are treated as shares present
or represented and
2
|
|
ZIMMER HOLDINGS, INC. |
2007 PROXY STATEMENT |
voting, so abstaining has the same effect as a vote
against the proposal. Broker non-votes on a proposal
are not counted or deemed to be present or represented for the
purpose of determining whether stockholders have approved that
proposal.
May I give my proxy to someone other than the individuals
listed on the proxy card?
If you are a registered stockholder and wish to give your proxy
to someone other than the individuals named on the proxy card,
you may do so by crossing out the names appearing on the proxy
card and inserting the name of another person. The person you
have designated on the proxy card must present the signed card
at the meeting.
Who tabulates the votes?
Representatives of ADP Investor Communications Services will
tabulate the votes and act as independent inspectors of election.
Who pays the cost of this proxy solicitation?
We will pay the costs of this solicitation. Our employees may
solicit proxies on behalf of the Board of Directors by mail,
telephone, facsimile, electronic transmission and personal
solicitation. In addition, we have retained The Altman Group,
Inc. to assist in soliciting proxies for a fee of $5,500, plus
out-of-pocket expenses.
We will, upon request, reimburse brokerage firms and others for
their reasonable expenses incurred for forwarding solicitation
material to beneficial holders of stock. Questions concerning
proxy voting or process should be directed to The Altman Group,
Inc. via telephone at
(800) 761-6578
(this call is toll-free in the United States).
Is there a list of stockholders entitled to vote at the
annual meeting?
A list of stockholders entitled to vote at the meeting will be
available at the meeting and for ten days prior to the meeting,
between the hours of 8:00 a.m. and 5:00 p.m., at our
offices at 345 East Main Street, Warsaw, Indiana. If you would
like to view the stockholder list, please contact our Corporate
Secretary to schedule an appointment.
Does the company offer an opportunity to receive future proxy
materials electronically?
Yes. If you are a stockholder of record, you may, if you wish,
receive future proxy statements and annual reports online. If
you elect this feature, you will receive an
e-mail message
notifying you when the materials are available along with a web
address for viewing the materials and instructions for voting by
telephone or the Internet. If you have more than one account,
you may receive separate
e-mail notifications
for each account. If you vote online as described above, you may
sign up for electronic delivery at that time.
If you hold your shares in a brokerage account, you may also
have the opportunity to receive proxy materials electronically.
Please follow the instructions of your broker.
PRINCIPAL STOCKHOLDERS
The following table sets forth certain information concerning
each person (including any group) known to us to beneficially
own more than five percent (5%) of our common stock as of
March 8, 2007. Unless otherwise noted, shares are owned
directly or indirectly with sole voting and investment power.
|
|
|
|
|
|
|
|
|
|
|
Total Number of | |
|
Percent | |
Name and Address of Beneficial Owner |
|
Shares Owned | |
|
of Class | |
|
|
| |
|
| |
Capital Research and Management
Company(1)
|
|
|
20,489,000 |
|
|
|
8.6 |
% |
333 South Hope Street
Los Angeles, California 90071 |
|
|
|
|
|
|
|
|
|
|
(1) |
Based solely on information provided by Capital Research and
Management Company, or Capital Research, and The Growth Fund of
America, Inc., or Growth Fund, in a Schedule 13G filed with
the Securities and Exchange Commission on February 12,
2007. Capital Research acts as an investment advisor to various
investment companies. Capital Research has sole voting power
over 4,839,000 shares of our common stock and sole
dispositive power over 20,489,000 shares (or 8.6%) of our
common stock. Capital Research has disclaimed beneficial
ownership of these shares. Growth Fund is an investment company
that is advised by Capital Research. Growth Fund has sole voting
power over 15,650,000 shares (or 6.6%) of our common stock. |
3
|
|
ZIMMER HOLDINGS, INC. |
2007 PROXY STATEMENT |
SECURITY OWNERSHIP OF DIRECTORS AND OFFICERS
The following table sets forth, as of January 3, 2007,
beneficial ownership of shares of our common stock by each
current director, each of the executives named in the Summary
Compensation Table and all current directors and executive
officers as a group. Unless otherwise noted, such shares are
owned directly or indirectly with sole voting and dispositive
power.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total | |
|
Shares | |
|
Deferred | |
|
Percent | |
|
|
Shares | |
|
Acquirable in | |
|
Share | |
|
of | |
Name |
|
Owned(1) | |
|
60 Days(2) | |
|
Units(3) | |
|
Class | |
|
|
| |
|
| |
|
| |
|
| |
J. Raymond Elliott
|
|
|
1,250,923 |
|
|
|
1,185,065 |
|
|
|
0 |
|
|
|
* |
|
Stuart M. Essig
|
|
|
3,036 |
|
|
|
1,316 |
|
|
|
1,720 |
|
|
|
* |
|
Larry C. Glasscock
|
|
|
59,042 |
(4) |
|
|
54,759 |
|
|
|
4,243 |
|
|
|
* |
|
Arthur J. Higgins
|
|
|
0 |
(5) |
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
John L. McGoldrick
|
|
|
66,372 |
|
|
|
50,000 |
|
|
|
5,040 |
|
|
|
* |
|
Augustus A. White, III, M.D., Ph.D.
|
|
|
25,998 |
|
|
|
22,000 |
|
|
|
3,998 |
|
|
|
* |
|
Sam R. Leno
|
|
|
487,718 |
|
|
|
455,262 |
(6) |
|
|
0 |
|
|
|
* |
|
Bruno A. Melzi
|
|
|
209,744 |
|
|
|
198,739 |
|
|
|
0 |
|
|
|
* |
|
David C. Dvorak
|
|
|
257,969 |
|
|
|
248,506 |
|
|
|
0 |
|
|
|
* |
|
Sheryl L. Conley
|
|
|
289,974 |
|
|
|
286,061 |
|
|
|
0 |
|
|
|
* |
|
All current directors and executive officers as a group
(15 persons)
|
|
|
3,177,922 |
|
|
|
2,997,858 |
|
|
|
15,001 |
|
|
|
1.3 |
% |
* Less than 1.0%
|
|
(1) |
Includes direct and indirect ownership of shares, stock options
that are currently exercisable and stock options that will be
exercisable within 60 days of January 3, 2007,
deferred share units and the following restricted shares, which
are subject to vesting requirements: Mr. Leno
5,000; Mr. Dvorak 7,500; and all directors and
executive officers as a group 17,500. |
(2) |
Includes stock options that are currently exercisable and stock
options that will be exercisable within 60 days of
January 3, 2007. |
(3) |
Amounts credited to directors accounts in the Restated
Zimmer Holdings, Inc. Deferred Compensation Plan for
Non-Employee Directors as deferred share units that will be paid
in shares of our common stock within 60 days after
cessation of the individuals service as a director. |
(4) |
Includes 40 shares held in a trust with respect to which
Mr. Glasscock shares voting authority with the trustee. |
(5) |
Mr. Higgins joined the Board of Directors effective
February 12, 2007. |
(6) |
1,667 of these shares vest within 60 days of
January 3, 2007. Upon vesting, one-half of the shares will
be transferred to Mr. Lenos former spouse pursuant to
a domestic relations order. |
SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING
COMPLIANCE
Under Section 16(a) of the Securities Exchange Act of 1934,
as amended, or the Exchange Act, our directors, executive
officers and the beneficial holders of more than 10% of our
common stock are required to file reports of ownership and
changes in ownership with the Securities and Exchange
Commission. Based on our records and other information, we
believe that during 2006 all applicable Section 16(a)
filing requirements were met.
CORPORATE GOVERNANCE
Our business is managed under the direction of the Board of
Directors. The Board has responsibility for establishing broad
corporate policies and for our overall performance.
Policies on Corporate Governance
We are committed to maintaining the highest standards of
business conduct and corporate governance, which we believe are
essential to running our business efficiently, serving
stockholders well and maintaining our integrity in the
marketplace. We have adopted a Code of Business Conduct that
applies to all directors, officers and employees and a Code of
Ethics for Chief Executive Officer and Senior Financial
Officers. The Board of Directors has adopted Corporate
Governance Guidelines, which, in conjunction with the Restated
Certificate of Incorporation, Restated By-Laws, as amended,
Board committee charters and key Board policies, form the
framework for our governance. The current version of the Code of
Business Conduct, the Code of Ethics for Chief Executive Officer
and Senior Financial Officers, the Boards Corporate
Governance Guidelines and the charters for each of the Audit
Committee, Compensation and Management Development Committee,
Corporate Governance Committee and Science and Technology
Committee, as well as the Boards policies on auditor
ratification and stockholder rights plans, are available in the
Investor Relations/ Corporate Governance section of our website,
www.zimmer.com, and will be provided in print without charge
upon written request to our Corporate Secretary at the address
shown on the cover page of this proxy statement. We will either
disclose on
Form 8-K or post
on our website any substantive amendment to, or waiver from, the
Code of Ethics for Chief Executive Officer and Senior Financial
Officers or a provision of the Code of Business Conduct that
applies to any of our directors or executive officers. The Board
regularly reviews corporate governance developments and modifies
its
4
|
|
ZIMMER HOLDINGS, INC. |
2007 PROXY STATEMENT |
Corporate Governance Guidelines, committee charters and key
practices as warranted. During 2006, the Board approved an
amendment to our Restated By-Laws to adopt a majority vote
standard for the election of directors in uncontested elections.
This standard is explained in more detail below.
Director Independence
As permitted by the rules of the New York Stock Exchange, the
Board has adopted categorical standards to assist it in making
determinations of director independence. These standards
incorporate, and are consistent with, the definition of
independent contained in the New York Stock Exchange
listing rules. These standards are set forth in Appendix A
to this proxy statement and are also included in the
Boards Corporate Governance Guidelines, which are
available on our website as described above. The Board has
determined that each of our non-employee directors, Stuart M.
Essig, Larry C. Glasscock, Arthur J. Higgins, John L. McGoldrick
and Augustus A. White, III, M.D., Ph.D., meets
these standards and is independent. The Board has determined
that J. Raymond Elliott, who is an employee, is not independent.
In making its determination with respect to Mr. Essig, the
Board considered his position as President and Chief Executive
Officer of Integra LifeSciences Holdings Corporation, or
Integra, a medical device company from which we purchase certain
dental products. During 2006, the amount we paid Integra
exceeded $1,000,000 but represented less than 1.00% of
Integras gross revenues. Similarly, in making its
determination with respect to Mr. Glasscock, the Board
considered his position as Chairman, President and Chief
Executive Officer of WellPoint, Inc., the largest commercial
health benefits company in terms of membership in the United
States and our primary health benefits provider. During 2006,
the amount we paid WellPoint exceeded $1,000,000 but represented
less than 0.1% of WellPoints gross revenues. After
reviewing the terms of these transactions and the relationships
that Messrs. Essig and Glasscock have with their respective
employers, the Board determined that neither director has a
direct or indirect material interest in the transactions and
that our business relationships with their employers do not
diminish the ability of either director to exercise his
independent judgment on issues affecting our business.
Adoption of Majority Vote Standard for Election of
Directors
In September 2006, the Board approved an amendment to our
Restated By-Laws to require directors to be elected by the
majority of the votes cast with respect to that director in
uncontested elections (number of shares voted for a
director must exceed the number of votes cast
against that director). In a contested
election (a situation in which the number of nominees
exceeds the number of directors to be elected), the standard for
election of directors will be a plurality of the shares
represented in person or by proxy at any such meeting and
entitled to vote on the election of directors. If a nominee who
is serving as a director is not elected at the annual meeting,
under Delaware law the director would continue to serve on the
Board as a holdover director. However, under our
Restated By-Laws, as amended, any director who fails to be
elected must offer to tender his or her resignation to the
Board. The Corporate Governance Committee would then make a
recommendation to the Board whether to accept or reject the
resignation, or whether other action should be taken. The Board
will act on the Corporate Governance Committees
recommendation and publicly disclose its decision and the
rationale behind it within 90 days from the date the
election results are certified. The director who tenders his or
her resignation will not participate in the Boards
decision. If a nominee who was not already serving as a director
is not elected at the annual meeting, under Delaware law that
nominee would not become a director and would not serve on the
Board as a holdover director. In 2007, all nominees
for election as directors are currently serving on the Board.
Nominations for Directors
The Corporate Governance Committee will consider director
nominees recommended by stockholders. A stockholder who wishes
to recommend a director candidate for consideration by the
Corporate Governance Committee should send such recommendation
to our Corporate Secretary at the address shown on the cover
page of this proxy statement, who will then forward it to the
committee. Any such recommendation should include a description
of the candidates qualifications for board service, the
candidates written consent to be considered for nomination
and to serve if nominated and elected, and addresses and
telephone numbers for contacting the stockholder and the
candidate for more information. A stockholder who wishes to
nominate an individual as a director candidate at the annual
meeting of stockholders, rather than recommend the individual to
the Corporate Governance Committee as a nominee, must comply
with the advance notice requirements set forth in our Restated
By-Laws, as amended (see 2008 Proxy Proposals for
more information on these procedures).
In considering candidates for the Board, the Corporate
Governance Committee considers the entirety of each
candidates credentials and does not have any specific
minimum qualifications that must be met by a
committee-recommended nominee. The committee is guided by the
following basic selection criteria for all nominees:
independence; highest character and integrity; experience and
understanding of strategy and policy-setting; reputation for
working constructively with others; and sufficient time to
devote to Board matters. The committee also gives consideration
to diversity, age, international background and experience and
specialized expertise in the context of the needs of the Board
as a whole. During the past year, we paid a
5
|
|
ZIMMER HOLDINGS, INC. |
2007 PROXY STATEMENT |
fee to a third-party search firm to assist the committee in
identifying and evaluating potential director candidates. One of
the candidates identified by the firm, Arthur J. Higgins, joined
the Board of Directors effective February 12, 2007.
Stockholder Communication with the Board
The Board has implemented a process whereby our stockholders may
send communications to the Boards attention. Any
stockholder desiring to communicate with the Board, or one or
more specified members thereof, should communicate in a writing
addressed to Zimmer Holdings, Inc., Board of Directors,
c/o Corporate Secretary, at the address shown on the cover
page of this proxy statement. The Board has instructed our
Corporate Secretary to promptly forward all such communications
to the specified addressees thereof.
Conflicts of Interest Policy
On an annual basis, each director and executive officer is
obligated to complete a director and officer questionnaire which
requires disclosure of any transactions with us in which the
director or executive officer, or any member of his or her
immediate family, has an interest. The Audit Committee is
charged with reviewing and approving any related person
transaction in which any executive officer, director, director
nominee or more than 5% stockholder of the company, or any of
their immediate family members, has a direct or indirect
material interest. Our Compliance Officer or an attorney in our
Legal Department is charged with reviewing any conflict of
interest involving any other employee.
MEETINGS AND COMMITTEES OF THE BOARD
Meetings and Attendance
The Board meets on a regularly scheduled basis during the year
to review significant developments affecting us and to act on
matters requiring Board approval. It also holds special meetings
when an important matter requires Board action between scheduled
meetings. Members of senior management regularly attend Board
meetings to report on and discuss their areas of responsibility.
Directors are also expected to attend the annual meeting of
stockholders. All of the directors then in office attended the
2006 annual meeting. In 2006, the Board of Directors held seven
meetings and committees of the Board held a total of 29
meetings. Overall attendance at these meetings was 99%. Each
director attended more than 75% of the total meetings of the
Board of Directors and each of the committees on which he served
during 2006.
Executive Sessions of and Communication with Non-Management
Directors
Non-management directors meet in executive sessions without
management present upon the adjournment of every regularly
scheduled meeting of the Board and at other times they
determine. The director who presides at these meetings rotates
session-by-session among the non-management directors in
alphabetical order of their last names.
In order that interested parties may be able to make their
concerns known to the non-management directors, the Board has
adopted a method for communicating directly with the
non-management directors. The Board has designated Stuart M.
Essig to receive such communications on behalf of the
non-management directors. Interested parties may contact
Mr. Essig via
e-mail
at .
Committees of the Board
Our Restated By-Laws provide that the Board may delegate
responsibility to committees. During 2006, the Board had four
standing committees: an Audit Committee established in
accordance with Section 3(a)(58)(A) of the Exchange Act, a
Compensation and Management Development Committee, a Corporate
Governance Committee and a Science and Technology Committee. The
membership of each of the Audit Committee, the Compensation and
Management Development Committee and the Corporate Governance
Committee is composed entirely of independent directors. In
addition, the members of the Audit Committee meet the heightened
standards of independence for audit committee members required
by Securities and Exchange Commission rules and New York Stock
Exchange listing standards. The membership of the Science and
Technology Committee is composed of two independent directors
and one employee representative, and the committee works
together with an Advisory Board of Science and Technology.
6
|
|
ZIMMER HOLDINGS, INC. |
2007 PROXY STATEMENT |
The table below shows the current membership of each Board
committee and the number of meetings held during 2006.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation | |
|
|
|
|
|
|
|
|
and | |
|
|
|
Science | |
|
|
|
|
Management | |
|
Corporate | |
|
and | |
Name |
|
Audit | |
|
Development | |
|
Governance | |
|
Technology | |
|
|
| |
|
| |
|
| |
|
| |
Stuart M. Essig
|
|
|
X |
|
|
|
Chair |
|
|
|
X |
|
|
|
|
|
Larry C. Glasscock
|
|
|
Chair |
|
|
|
X |
|
|
|
X |
|
|
|
|
|
Arthur J. Higgins*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
John L. McGoldrick
|
|
|
|
|
|
|
X |
|
|
|
Chair |
|
|
|
X |
|
Augustus A. White, III, M.D., Ph.D.
|
|
|
X |
|
|
|
X |
|
|
|
X |
|
|
|
Chair |
|
2006 Meetings
|
|
|
14 |
|
|
|
6 |
|
|
|
7 |
|
|
|
2 |
|
|
|
|
|
* |
Mr. Higgins joined the Board of Directors effective
February 12, 2007. He will be appointed to the Audit
Committee, the Compensation and Management Development Committee
and the Corporate Governance Committee effective March 30,
2007. |
Audit Committee. The principal functions of the Audit
Committee include:
|
|
|
|
|
appointing, evaluating and, where appropriate, replacing our
independent registered public accounting firm; |
|
|
|
preapproving all auditing services and permissible non-audit
services provided to us by our independent registered public
accounting firm; |
|
|
|
reviewing with our independent registered public accounting firm
and with management the proposed scope of the annual audit, past
audit experience, our program for the internal examination and
verification of our accounting records and the results of
recently completed internal examinations; |
|
|
|
resolving disagreements between management and our independent
registered public accounting firm regarding financial reporting;
and |
|
|
|
reviewing major issues as to the adequacy of our internal
controls. |
The Board of Directors has determined that both Larry C.
Glasscock and Stuart M. Essig qualify as audit committee
financial experts as defined by rules of the Securities
and Exchange Commission. Stockholders should understand that
this designation is an SEC disclosure requirement related to
these directors experience and understanding with respect
to certain accounting and auditing matters. The designation does
not impose upon these directors any duties, obligations or
liability that are greater than are generally imposed on them as
members of the Audit Committee and the Board, and their
designation as audit committee financial experts pursuant to
this SEC requirement does not affect the duties, obligations or
liability of any other member of the Audit Committee or the
Board.
The report of the Audit Committee appears below.
Compensation and Management Development Committee. The
duties of the Compensation and Management Development Committee
include:
|
|
|
|
|
administering our annual incentive, stock option and long-term
incentive plans; |
|
|
|
reviewing and making recommendations to the Board with respect
to incentive compensation and equity-based plans; |
|
|
|
adopting and reviewing our management development programs and
procedures; |
|
|
|
approving compensation of executive officers and certain senior
management; and |
|
|
|
discussing with management the Compensation Discussion and
Analysis required by Securities and Exchange Commission
regulations and, if appropriate, recommending its inclusion in
our Annual Report on
Form 10-K and
proxy statement. |
The report of the Compensation and Management Development
Committee appears on page .
Corporate Governance Committee. The duties of the
Corporate Governance Committee include:
|
|
|
|
|
developing and recommending to the Board criteria for selection
of non-employee directors; |
|
|
|
recommending director candidates to the Board; |
|
|
|
periodically reviewing both employee and non-employee director
performance; |
|
|
|
periodically reassessing the Boards Corporate Governance
Guidelines and recommending any proposed changes to the Board
for approval; and |
|
|
|
periodically reviewing, in cooperation with the Compensation and
Management Development Committee, the form and amount of
non-employee director compensation and recommending any proposed
changes to the Board for approval. |
7
|
|
ZIMMER HOLDINGS, INC. |
2007 PROXY STATEMENT |
Science and Technology Committee. The duties of the
Science and Technology Committee include:
|
|
|
|
|
advising the Board on matters involving our new science and
advanced technology programs, including major internal projects,
interactions with academic and independent research
organizations and the acquisition of technologies; and |
|
|
|
reviewing and recommending to the Board major technology
positions and strategies relative to emerging concepts of
therapy, new trends in healthcare, and changing market
requirements. |
AUDIT COMMITTEE REPORT
The Audit Committee is responsible for monitoring the integrity
of the companys financial statements, the qualifications,
performance and independence of the independent registered
public accounting firm, the performance of the companys
internal audit function and compliance with legal and regulatory
requirements. The committee is directly responsible for the
appointment, compensation, retention and oversight of the work
of the independent registered public accounting firm.
Management is responsible for the financial reporting process,
including the system of internal control, for the preparation of
consolidated financial statements in accordance with accounting
principles generally accepted in the United States and for
managements report on internal control over financial
reporting. The independent registered public accounting firm is
responsible for auditing the consolidated financial statements
and expressing an opinion as to their conformity with accounting
principles generally accepted in the United States as well as
rendering an opinion on managements report on internal
control over financial reporting. The committees
responsibility is to oversee and review the financial reporting
process and to review and discuss managements report on
internal control over financial reporting. Committee members are
not, however, professionally engaged in the practice of
accounting or auditing and do not provide any expert or other
special assurance as to such financial statements concerning
compliance with laws, regulations or accounting principles
generally accepted in the United States or as to the
independence of the independent registered public accounting
firm. The committee relies, without independent verification, on
the information provided to it and on the representations made
by management and the independent registered public accounting
firm.
The committee held 14 meetings during 2006. The meetings were
designed, among other things, to facilitate and encourage
communication among the committee, management, the internal
auditor and the independent registered public accounting firm,
PricewaterhouseCoopers LLP, or PwC.
The committee discussed with the internal auditor and PwC the
overall scope and plans for their respective audits. The
committee met with the internal auditor and PwC, with and
without management present, to discuss the results of their
examinations and their evaluations of the companys
internal control over financial reporting. The committee
reviewed and discussed compliance with Section 404 of the
Sarbanes-Oxley Act of 2002, including consideration of the
Public Company Accounting Oversight Boards
(PCAOB) Auditing Standard No. 2, An Audit of Internal
Control over Financial Reporting Performed in Conjunction With
an Audit of Financial Statements.
The committee discussed major financial risk exposures with
management and the steps management has taken to monitor and
control such exposures, including risk assessment and risk
management policies.
Management has represented to the committee that the
consolidated financial statements were prepared in accordance
with accounting principles generally accepted in the United
States, and the committee has reviewed and discussed the
consolidated financial statements with management and PwC. The
committee reviewed and discussed with management, the internal
auditor and PwC managements report on internal control
over financial reporting and PwCs report thereon. The
committee also discussed with management and the internal
auditor the process used to support certifications by the Chief
Executive Officer and Chief Financial Officer that are required
by the Securities and Exchange Commission and the Sarbanes-Oxley
Act of 2002 to accompany periodic filings with the Securities
and Exchange Commission and the processes used to support
managements report on internal control over financial
reporting.
The committee also discussed with PwC all matters required to be
discussed by that firms professional standards, including,
among other things, matters related to the conduct of the audit
of the consolidated financial statements and the matters
required to be discussed by Statement on Auditing Standards
No. 61, as amended (AICPA, Professional Standards,
Vol. 1 AU Section 380, Communication with Audit
Committees), as adopted by the Public Company Accounting
Oversight Board in Rule 3200 T.
PwC provided to the committee the written disclosures and the
letter required by Independence Standards Board Standard
No. 1 (Independence Discussions with Audit
Committees), as adopted by the Public Company Accounting
Oversight Board in Rule 3600 T, and represented that PwC is
independent from the company. The committee also discussed with
PwC its independence from the company. When considering
PwCs independence, the committee considered if services
PwC provided to the company beyond those rendered in connection
with its audit and related reviews of the consolidated financial
statements and attestation on managements report on
internal control over financial reporting, were compatible with
maintaining its independence. The committee concluded that the
provision of such services by PwC has not jeopardized PwCs
independence.
8
|
|
ZIMMER HOLDINGS, INC. |
2007 PROXY STATEMENT |
Based on the reviews and discussions described above, and
subject to the limitations on the committees role and
responsibilities referred to above and in the charter of the
Audit Committee, the committee recommended to the Board of
Directors, and the Board approved, that the audited consolidated
financial statements for the year ended December 31, 2006
be included in the Annual Report on
Form 10-K for
filing with the Securities and Exchange Commission.
The committee has also confirmed there have been no new
circumstances or developments since their respective
appointments to the Audit Committee that would impair any
members ability to act independently.
|
|
|
Larry C. Glasscock, Chair |
|
Stuart M. Essig |
|
Augustus A. White, III, M.D., Ph.D. |
DIRECTORS AND NOMINEES
The Board of Directors is divided into three classes whose terms
expire at successive annual meetings. Two directors will be
elected at the meeting to serve a term expiring in 2010. If
stockholders approve Proposal 3 to require the annual
election of all directors, then directors elected after this
meeting will serve annual terms. The nominees for director named
below are currently our directors. Each of
Messrs. Glasscock and McGoldrick has been a director since
2001 and was last elected by stockholders in 2004. After the
election of two directors at the meeting, we will have six
directors, including the four directors whose present terms
extend beyond the meeting. Listed first below are the nominees
for election, followed by the directors whose terms expire in
2008 and 2009, with information including their principal
occupations and other business affiliations, the year each was
first elected as a director, the Board committee memberships of
each and each directors age.
Nominees for Director: 2007 2010 Term
|
|
|
|
|
Larry C. Glasscock, Director Since 2001
Chairman, President and Chief Executive Officer of
WellPoint, Inc. (formerly known as Anthem, Inc.) since November
2005. Mr. Glasscock was elected Chairman of the Board on
November 30, 2005, having served as President and Chief
Executive Officer of WellPoint, Inc. since November 2004.
Mr. Glasscock served as Chairman, President and Chief
Executive Officer of Anthem, Inc. from May 2003 to November 2004
and has served as President and Chief Executive Officer of
Anthem Insurance Companies, Inc., or Anthem Insurance, since
October 1999. Mr. Glasscock joined Anthem Insurance in
April 1998 as Senior Executive Vice President and Chief
Operating Officer. He was named President and Chief Operating
Officer in April 1999 and President and Chief Executive Officer
in October 1999. Mr. Glasscock was named President and
Chief Executive Officer of Anthem, Inc. in July 2001. In
February 2007, Mr. Glasscock announced that he will retire
as President and Chief Executive Officer of WellPoint, Inc.
effective June 1, 2007. He will continue to serve as
Chairman of the Board. Prior to joining Anthem Insurance,
Mr. Glasscock served as Chief Operating Officer of
CareFirst, Inc. from January through April 1998 and he served as
President and Chief Executive Officer of Group
Hospitalization & Medical Services, Inc., which did
business as Blue Cross and Blue Shield of the National Capital
Area, from September 1993 to January 1998. From 1991 to 1993, he
served as President, Chief Operating Officer and Director of
First American Bank, N.A. Mr. Glasscock is a director of
WellPoint, Inc. Board Committees: Audit Committee (Chair),
Compensation and Management Development Committee and Corporate
Governance Committee. Age 58. |
9
|
|
ZIMMER HOLDINGS, INC. |
2007 PROXY STATEMENT |
|
|
|
Nominees for Director: 2007 2010 Term
(continued) |
|
 |
|
John L. McGoldrick, Director Since 2001
Senior Vice President, External Strategy Development,
International AIDS Vaccine Initiative since May 2006.
Mr. McGoldrick served as Executive Vice President of
Bristol-Myers Squibb Company, or Bristol-Myers Squibb, from
October 2005 until his retirement in April 2006. He held the
position of Executive Vice President and General Counsel of
Bristol-Myers Squibb from January 2000 to October 2005. Prior to
that, he held the position of Senior Vice President, General
Counsel and President, Medical Devices Group from December 1998
to January 2000 and Senior Vice President and General Counsel
from 1995 to December 1998. He served as senior director of the
Board of the New Jersey Transit Corporation and a member of the
board of the Advanced Medical Technology Association, or
AdvaMed, the medical device industrys trade association,
from 1998 to 2002. Mr. McGoldrick has served on several
governmental reform commissions in New Jersey. He is an invited
participant of The Aspen Institute on the World Economy and the
World Economic Forum (Davos). Before joining Bristol-Myers
Squibb, Mr. McGoldrick was a senior partner and executive
committee member of the law firm of McCarter & English.
He is a graduate of Harvard College and the Harvard Law School.
Board Committees: Compensation and Management Development
Committee, Corporate Governance Committee (Chair) and Science
and Technology Committee. Age 66. |
|
Continuing Directors Whose Present Terms Expire in 2008 |
|
 |
|
J. Raymond Elliott, Director Since 2001
Chairman, President and Chief Executive Officer of Zimmer
Holdings, Inc. since August 6, 2001. President, Chief
Executive Officer and Director since March 20, 2001.
Mr. Elliott was appointed President of Zimmer, Inc. in
November 1997. In November 2006, Mr. Elliott announced that
he plans to retire as President and Chief Executive Officer of
Zimmer Holdings, Inc. during the first half of 2007, assuming a
successor CEO has been named. He will remain Chairman through at
least November 2007. Mr. Elliott has more than
35 years of experience in orthopaedics, medical devices and
consumer products. Prior to joining Zimmer, Inc., he served as
President and Chief Executive Officer of Cybex, Inc., a publicly
traded medical products company, from September 1995 to June
1997, and previously as President and Chief Executive Officer of
J.R. Elliott & Associates, a privately held M&A
firm. During this time, Mr. Elliott successfully completed
several M&A and turnaround projects for the Federal
government and numerous healthcare firms, including the role of
Chairman and Chief Executive Officer for Cablecom Inc.
Mr. Elliott has also served as Chairman and President of
various divisions of Southam, Inc., a communications group, and
as Group President of food and beverage leader John Labatt, Inc.
He began his career in the healthcare industry with American
Hospital Supply Corporation (later Baxter International), where
he gained 15 years experience in sales, marketing,
operations, business development and general management, leading
to his appointment as President of the Far East divisions, based
in Tokyo, Japan. Mr. Elliott has served as a director on
more than 20 business-related boards in the U.S., Canada, Japan
and Europe and has served on five occasions as Chairman. He has
served as a member of the board of directors and chair of the
orthopaedic sector of AdvaMed and is currently a director of the
State of Indiana Workplace Development Board, the Indiana
Chamber of Commerce and the American Swiss Foundation.
Mr. Elliott also has served as the Indiana representative
on the Presidents State Scholars Program and as a trustee
of the Orthopaedic Research and Education Foundation, or OREF.
He holds a bachelors degree from the University of Western
Ontario, Canada. Age 57. |
10
|
|
ZIMMER HOLDINGS, INC. |
2007 PROXY STATEMENT |
|
|
|
Continuing Directors Whose Present Terms Expire in 2008
(continued) |
|
 |
|
Arthur J. Higgins, Director Since 2007
Chairman of the Board of Management of Bayer HealthCare AG
since January 2006 and Chairman of the Bayer HealthCare
Executive Committee since July 2004. Prior to joining Bayer
Healthcare, Mr. Higgins served as Chairman, President and
Chief Executive Officer of Enzon Pharmaceuticals, Inc. from 2001
to 2004. In this function, he also served as Chairman of the
Biotechnology Council of New Jersey and on the board of the
National Pharmaceutical Council. Prior to joining Enzon
Pharmaceuticals, Mr. Higgins spent 14 years with
Abbott Laboratories, most recently as President of the
Pharmaceutical Products Division from 1998 to 2001. In this
position he was in charge of Abbott Laboratories
pharmaceuticals business in the United States with
responsibility for global pharmaceutical research and
development. Mr. Higgins began his career in 1978 in
Britain with Bristol-Myers. He then worked for Sandoz (1979 to
1984) and Fisons (1984 to 1987) prior to moving to Abbott
Laboratories in the United States in 1987. He is a member of the
Board of Directors of the Pharmaceutical Research and
Manufacturers of America (PhRMA), a member of the Council of the
International Federation of Pharmaceutical Manufacturers and
Associations (IFPMA) and Vice President of the European
Federation of Pharmaceutical Industries and Associations
(EFPIA). Mr. Higgins graduated from Strathclyde University,
Scotland and holds a B.S. in biochemistry. Effective
March 30, 2007, he will be appointed to the Audit
Committee, the Compensation and Management Development Committee
and Corporate Governance Committee of the Board of Directors.
Age 51. |
|
Continuing Directors Whose Present Terms Expire in 2009 |
|
 |
|
Stuart M. Essig, Director Since 2005
President and Chief Executive Officer of Integra
LifeSciences Holdings Corporation, or Integra, since December
1997. Prior to joining Integra, Mr. Essig supervised the
medical technology practice at Goldman, Sachs & Co. as
a managing director. Mr. Essig had ten years of experience
at Goldman Sachs serving as a senior mergers and acquisitions
advisor to a broad range of domestic and international medical
technology, pharmaceutical and biotechnology clients.
Mr. Essig holds an A.B. from the Woodrow Wilson School of
Public and International Affairs at Princeton University and an
M.B.A. and Ph.D. in Financial Economics from the University of
Chicago, Graduate School of Business. Mr. Essig is a
director of Integra, St. Jude Medical, Inc. and AdvaMed. Board
Committees: Audit Committee, Compensation and Management
Development Committee (Chair) and Corporate Governance
Committee. Age 45. |
|
 |
|
Augustus A. White, III, M.D., Ph.D.,
Director Since 2001
Ellen and Melvin Gordon Professor of Medical Education,
Professor of Orthopaedic Surgery, and former Master of the
Oliver Wendell Holmes Society at the Harvard Medical School and
Professor of Orthopaedic Surgery at the Harvard-MIT Division of
Health Sciences and Technology; and Orthopaedic
Surgeon-in-Chief, Emeritus, at the Beth Israel Deaconess Medical
Center in Boston. Dr. White previously served as the Chief
of Spine Surgery at Beth Israel and Director of the Daniel E.
Hogan Spine Fellowship Program. He is a graduate of the Stanford
University Medical School, holds a Ph.D. from the Karolinska
Institute in Stockholm and an A.B. from Brown University, and
graduated from the Advanced Management Program at the Harvard
Business School. Dr. White is a recipient of the Bronze
Star, which he earned while stationed as a Captain in the
U.S. Army Medical Corps in Vietnam. He is an
internationally known and widely published authority on
biomechanics of the spine, fracture healing and surgical and
non-surgical care of the spine. He is nationally recognized for
his work in medical education, diversity, and issues of health
care disparities. Dr. White is a director of Orthologic
Corp. Board Committees: Audit Committee, Compensation and
Management Development Committee, Corporate Governance Committee
and Science and Technology Committee (Chair). Age 70. |
11
|
|
ZIMMER HOLDINGS, INC. |
2007 PROXY STATEMENT |
EXECUTIVE COMPENSATION
[To be included in Definitive Proxy Statement]
DIRECTOR COMPENSATION
[To be included in Definitive Proxy Statement]
Compensation Committee Interlocks and Insider
Participation
None of the members of the Compensation and Management
Development Committee during 2006 or as of the date of this
proxy statement is or has been our officer or employee or had
any relationship requiring disclosure under Item 404 of
Regulation S-K of
the Securities and Exchange Commission. None of our executive
officers served on the compensation committee or board of any
company that employed any member of the Compensation and
Management Development Committee or Board of Directors or
otherwise under circumstances requiring disclosure under
Item 404 of
Regulation S-K.
Equity Compensation Plan Information
The following table gives information about our common stock
that may be issued upon the exercise of options, warrants and
rights under all of our equity compensation plans as of
December 31, 2006, including the 2006 Stock Incentive Plan,
as amended, the 2001 Stock Incentive Plan, as amended, the
TeamShare Stock Option Plan, as amended, the Stock Plan for
Non-Employee Directors, as amended, the Restated Deferred
Compensation Plan for Non-Employee Directors, the Employee Stock
Purchase Plan, as amended, and the Independent Sales
Representatives Deferred Annual Final Compensation and Equity
Incentive Plan.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A | |
|
B | |
|
C | |
|
|
| |
|
| |
|
| |
|
|
|
|
|
|
Number of securities | |
|
|
Number of securities to | |
|
|
|
remaining available for | |
|
|
be | |
|
|
|
future issuance under | |
|
|
issued upon exercise of | |
|
Weighted-average exercise | |
|
equity compensation plans | |
|
|
outstanding options, | |
|
price of outstanding options, | |
|
(excluding securities reflected | |
Plan Category |
|
warrants and rights (#) | |
|
warrants and rights ($) | |
|
in column (A))(#) | |
|
|
| |
|
| |
|
| |
Equity compensation plans approved |
|
|
15,153,889 |
(3) |
|
$ |
59.75 |
(4) |
|
|
20,945,905 |
(5)(6)(7)(8) |
|
by security
holders(1)(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity compensation plans not approved
|
|
|
216,472 |
(10) |
|
|
N/A |
(11) |
|
|
533,528 |
|
|
by security
holders(9)
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
15,370,361 |
|
|
$ |
59.75 |
|
|
|
21,479,433 |
|
|
|
|
|
(1) |
Consists of the 2006 Stock Incentive Plan, as amended, the 2001
Stock Incentive Plan, as amended, the TeamShare Stock Option
Plan, as amended, the Stock Plan for Non-Employee Directors, as
amended, the Restated Deferred Compensation Plan for Non-
Employee Directors and the Employee Stock Purchase Plan, as
amended. |
|
|
(2) |
The table does not take into account the Executive Performance
Incentive Plan, which provides for the payment of incentive
compensation to certain key executives and which has been
approved by security holders. The Compensation and Management
Development Committee of the Board of Directors administers the
plan and has adopted regulations requiring all payments with
respect to awards under the plan be made in cash. |
|
|
(3) |
Includes 1,502,757 options granted prior to our separation from
our former parent with respect to common stock of the former
parent which were replaced on August 7, 2001 with options
to purchase our common stock. The replacement options were
intended to preserve the economic value of the original options
at the time of the separation. The number of shares of our
common stock covered by replacement options was calculated by
multiplying the number of shares of common stock of the former
parent under the original options by a factor of 2.03614, and
the exercise price of the options was decreased by dividing the
original exercise price by the same factor. The weighted-average
exercise price of the outstanding replacement options as of
December 31, 2006 was $28.72. Also includes shares which
may be issued pursuant to the following outstanding awards:
(1) 15,001 deferred share units issued pursuant to the
terms of the Restated Deferred Compensation Plan for
Non-Employee Directors, as described in footnote (7) below,
(2) 909,397 performance shares issued pursuant to the terms
of the 2001 Stock Incentive Plan, or the 2001 Plan and
(3) 1,000 restricted stock units issued pursuant to the
terms of the 2006 Stock Incentive Plan, or the 2006 Plan. |
|
|
(4) |
Represents the weighted average exercise price of outstanding
options. Does not take into consideration outstanding deferred
share units, performance shares or restricted stock units,
which, once vested, may be converted into shares of our common
stock on a one-for-one basis upon distribution at no additional
cost. |
|
|
(5) |
No shares remain available for future issuance under the 2001
Plan, which by its terms expired in August 2006. The 2001 Plan
was replaced by the 2006 Plan, which provides for the grant of
incentive stock options, nonqualified stock options, stock
appreciation rights, restricted stock, restricted stock units,
performance units and performance shares. A maximum of
10,000,000 shares of our common stock may be issued
pursuant to awards under the 2006 Plan. Of the 10,000,000 total
shares that may be issued, no more than 1,000,000 shares
may be issued pursuant to restricted stock, restricted stock
unit, performance unit or performance share awards, and no more
than 1,000,000 shares may be issued pursuant to incentive
stock option awards. |
12
|
|
ZIMMER HOLDINGS, INC. |
2007 PROXY STATEMENT |
|
|
|
|
(6) |
The Stock Plan for Non-Employee Directors provides for the grant
of stock options, restricted stock and restricted stock units. A
maximum of 2,000,000 shares of our common stock may be
issued pursuant to awards under the plan. Of the 2,000,000 total
shares that may be issued, not more than 500,000 shares may
be issued pursuant to awards of restricted stock and restricted
stock units. |
|
|
(7) |
The Restated Deferred Compensation Plan for Non-Employee
Directors provides for the mandatory deferral of certain
compensation payable to our non-employee directors in the form
of deferred share units. When amounts are deferred, a
directors deferred compensation account is credited with
that number of deferred share units equal to the deferral amount
divided by the fair market value of a share of our common stock.
Such deferred share units are payable in shares of our common
stock after cessation of the individuals service as a
director. A maximum of 200,000 shares of our common stock
may be issued under the plan. |
|
|
(8) |
Includes 2,577,984 shares available for purchase under the
Employee Stock Purchase Plan, as amended. |
|
|
(9) |
Consists of the Independent Sales Representatives Deferred
Annual Final Compensation and Equity Incentive Plan, which is
described below. |
|
|
(10) |
This number is the sum of the actual deferred stock units
awarded under the plan as of December 31, 2006 (187,621)
and the number of deferred stock units that would have been
awarded (28,851) if all outstanding stock option units as of
December 31, 2006 (150,276) were converted into deferred
stock units as of December 31, 2006. |
|
(11) |
Deferred stock units are converted into shares of our common
stock on a one-for-one basis upon distribution at no additional
cost, but were acquired as described below. |
The Independent Sales Representatives Deferred Annual Final
Compensation and Equity Incentive Plan is an unfunded, deferred
compensation plan for our independent distributors. A
participant may allocate each years contribution to his or
her account in 10% increments among stock option units, deferred
stock units and a non-interest bearing deferred compensation
account. Neither stock option units nor deferred stock units
have any dividend or voting rights. A participants stock
option units will be converted into deferred stock units upon
the earlier of (1) the ten-year anniversary of the date of
grant of the applicable stock option unit, or (2) the date
of the termination of the participants distributor
agreement. Deferred stock units will be converted into shares of
common stock on a
one-to-one basis upon
distribution from the plan. Participants may elect to receive
distributions of their interest in the plan in annual
installments over a period of three to ten years. The maximum
number of shares that may be issued over the life of the plan is
750,000.
PROPOSAL 1. ELECTION OF DIRECTORS
Two directors are to be elected at the meeting for a three-year
term ending at the 2010 annual meeting. At the recommendation of
the Corporate Governance Committee, the Board has nominated
Larry C. Glasscock and John L. McGoldrick, who are presently our
directors, for election at this annual meeting. Unless proxy
cards are otherwise marked, the persons named as proxies will
vote all proxies received for the election of each of the
nominees.
If a nominee is unable or unwilling to serve as a nominee at the
time of the annual meeting, the persons named as proxies may
vote for a substitute nominee designated by the Board to fill
the vacancy or for the balance of the nominees, leaving a
vacancy. Alternatively, the Board may reduce its size. The Board
has no reason to believe that either of the nominees will be
unwilling or unable to serve if elected as a director.
THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT YOU VOTE
FOR EACH OF THE TWO NOMINEES FOR DIRECTOR.
PROPOSAL 2. RATIFICATION OF APPOINTMENT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Audit Committee has appointed PricewaterhouseCoopers LLP, or
PwC, as our independent registered public accounting firm for
2007. PwC has served as our independent registered public
accounting firm since 2001. Representatives of PwC attended all
meetings of the Audit Committee in 2006. We expect that
representatives of PwC will be present at the annual meeting and
will be available to respond to appropriate questions. They will
also have an opportunity to make a statement if they desire to
do so.
The Audit Committees appointment of PwC is being submitted
to the stockholders for ratification. If a majority of
stockholders voting on the matter do not ratify the selection,
the Audit Committee will reconsider its choice taking into
consideration the views of the stockholders and may, but will
not be required to, appoint a different independent registered
public accounting firm.
The following table shows the fees that we paid or accrued for
audit and other services provided by PwC for the years 2006 and
2005. All of the services described in the following fee table
were approved in conformity with the Audit Committees
pre-approval process, described below.
13
|
|
ZIMMER HOLDINGS, INC. |
2007 PROXY STATEMENT |
|
|
|
|
|
|
|
|
|
|
|
2006 | |
|
2005 | |
|
|
| |
|
| |
Audit
Fees(1)
|
|
$ |
3,717,000 |
|
|
$ |
3,958,000 |
|
Audit-Related
Fees(2)
|
|
|
106,000 |
|
|
|
0 |
|
Tax
Fees(3)
|
|
|
251,000 |
|
|
|
63,300 |
|
All Other Fees
|
|
|
0 |
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
$ |
4,074,000 |
|
|
$ |
4,021,300 |
|
|
|
|
|
|
|
|
|
|
(1) |
This category includes the audit of our annual financial
statements, the audit of managements assessment of our
internal control over financial reporting, and PwCs own
audit of our internal control over financial reporting, the
review of interim financial statements included in our quarterly
reports on
Form 10-Q and
services that are normally provided by the independent
registered public accounting firm in connection with statutory
and regulatory filings or engagements for those years. This
category also includes advice on accounting matters that arose
during, or as a result of, the audit or the review of interim
financial statements and statutory audits required by
non-U.S. jurisdictions. |
|
(2) |
This category consists of assurance and related services
provided by PwC that are reasonably related to the performance
of the audit or review of our financial statements and are not
reported above under Audit Fees. The services for
the fees disclosed under this category include employee benefit
plan audits, accounting research and consultation and
restructuring-related statutory audits for various countries. |
|
(3) |
This category consists of tax services provided by PwC for tax
compliance, tax advice and tax planning. |
Pre-Approval Policies and Procedures
The Audit Committee pre-approves all audit and permissible
non-audit services to be provided to us by our independent
registered public accounting firm prior to commencement of
services. Mr. Glasscock, Audit Committee Chairman, has the
delegated authority to pre-approve such services up to a
specified aggregate fee amount. These pre-approval decisions are
presented to the full Audit Committee at its next scheduled
meeting.
THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT YOU VOTE
FOR RATIFICATION OF THE APPOINTMENT OF PWC AS OUR
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2007.
PROPOSAL 3. APPROVAL OF AMENDMENTS TO THE RESTATED
CERTIFICATE OF INCORPORATION TO REQUIRE ANNUAL ELECTION OF ALL
DIRECTORS
Stockholders are being asked to approve a series of related
amendments to our Restated Certificate of Incorporation in order
to phase out the present three-year staggered terms of directors
and provide for the annual election of all directors. Under the
present classified board structure, the Board is divided into
three classes with directors elected to staggered three-year
terms. Approximately one-third of the directors stand for
election each year. If the declassification proposal is
approved, directors will be elected to one-year terms of office
after their three-year terms expire at the 2008, 2009 or 2010
annual meetings.
Classified boards have been widely adopted and have a long
history in corporate law. Our classified board structure has
been in place since the spin-off from our former parent in 2001.
Proponents of classified boards believe that they provide
continuity and stability to the board, facilitate a long-term
outlook by the board, and enhance the independence of
non-employee directors. On the other hand, an increasing number
of investors have come to believe that classified boards reduce
accountability of directors because they limit the ability of
stockholders to evaluate and elect all directors on an annual
basis.
In 2005, a stockholder submitted a proposal that was considered
at our 2006 annual meeting. The proposal requested that the
Board take the steps necessary to cause the annual election of
each director in the most expeditious manner possible. This
proposal received support from a majority of the votes cast at
the 2006 annual meeting.
The Board is committed to good corporate governance. The Board
has, on several occasions, considered the advantages and
disadvantages of maintaining a classified Board, and, in the
past, has concluded that the classified Board structure was in
our and our stockholders best interests. This year, the
Board requested that the Corporate Governance Committee
reconsider the various positions for and against a classified
Board, particularly in light of evolving corporate governance
practices and changing investor sentiment, including the level
of support for the declassification proposal considered at the
2006 annual meeting.
The Corporate Governance Committee consulted management and
outside advisors when it considered the various positions for
and against a classified Board. Based upon the analysis and
recommendation of the committee, the Board has determined that
amending the Restated Certificate of Incorporation to provide
for the annual election of all directors is in our and our
stockholders best interests at this time.
Implementing this proposal would require amending four separate
provisions in the Restated Certificate of Incorporation.
Delaware law requires any amendment to be adopted by the board
of directors, deemed advisable by the board and submitted to a
vote of stockholders. On September 14, 2006, the Board
unanimously adopted a resolution approving the proposed
amendments. The Board further deemed such amendments advisable
and is recommending that stockholders approve the amendments.
14
|
|
ZIMMER HOLDINGS, INC. |
2007 PROXY STATEMENT |
If the proposal is approved, the current classified Board
structure will be phased out as follows:
|
|
|
|
|
Current directors, including those elected to three-year terms
at the 2007 annual meeting, will continue to serve the remainder
of their elected terms; and |
|
|
|
Starting with the 2008 annual meeting, directors will be elected
annually so that by the 2010 annual meeting, all directors will
be elected annually. |
Vote Required
Approval of the amendments to the Restated Certificate of
Incorporation requires the affirmative vote of the holders of at
least eighty percent (80%) of the combined voting power of the
then-outstanding shares of all classes and series of our stock
entitled to vote generally in the election of directors (a
super-majority vote). An abstention on the proposal
will have the same effect as a vote against it.
Amendments to Restated Certificate of Incorporation
The following is a brief description of each of the proposed
amendments to the Restated Certificate of Incorporation:
|
|
|
|
1. |
Beginning at the 2008 Annual Meeting of Stockholders, Each Class
of Directors Up For Election Will Serve One-Year Terms. |
Article VII Section 7.01 of the Restated Certificate
of Incorporation currently provides that the Board of Directors
is to be divided into three classes, with the directors in each
class standing for election at every third annual meeting of
stockholders. If this proposal is adopted, this provision will
be amended to phase out the current division of the Board of
Directors into three classes and to provide instead for the
annual election of directors commencing with the class of
directors standing for election at the 2008 annual meeting of
stockholders. To ensure a smooth transition to the new system,
and to permit the current directors (including directors
nominated for election at the 2007 annual meeting) to serve out
the three-year terms to which the stockholders elected them, the
amendments will not shorten the term of any director elected at
or before the 2007 annual meeting. The new procedures would,
however, apply to all directors elected after the 2007 annual
meeting, including any current directors who are re-nominated
after their current terms expire. Thus, the current class of
directors who were elected at the 2005 annual meeting for a
three-year term expiring in 2008 would, if re-nominated, stand
for election at the 2008 annual meeting for one-year terms. At
the 2009 annual meeting, those directors, together with the
class of directors elected at the 2006 annual meeting for a
three-year term expiring in 2009, would, if re-nominated, stand
for election for one-year terms. Beginning with the 2010 annual
meeting, the classification of the Board would end and all
directors would be subject to annual election.
|
|
|
|
2. |
All Directors Elected to Fill Future Vacancies Will Serve
One-Year Terms. |
Article VII Section 7.03 of the Restated Certificate
of Incorporation currently provides that directors elected to
fill vacancies (either as a result of newly-created
directorships or the death, resignation, disqualification, or
removal of a director) are to hold office for the remainder of
the full term of the class of directors in which the new
directorship was created or the vacancy occurred. If the
declassification proposal is approved, Article VII
Section 7.03 would be amended to provide that any directors
that are elected to fill vacancies on the Board serve for a term
ending at the next annual meeting of stockholders following
their election.
|
|
|
|
3. |
Directors Can Be Removed From Office Without Cause. |
Article VII Section 7.04 of the Restated Certificate
of Incorporation currently provides that directors may only be
removed from office for cause and with a super-majority vote in
favor of removal. Under Delaware corporate law, stockholders may
be limited to removing directors only for cause, but only if the
company has a classified board structure. For Delaware
corporations without a classified board, the holders of a
majority of the voting stock are entitled to remove directors
with or without cause. Accordingly, if this proposal is
approved, Article VII Section 7.04 would be amended to
eliminate the provision that directors may be removed only for
cause and the super-majority requirement. Under Delaware law,
directors cannot be removed by other directors, and the proposal
will not change this.
|
|
|
|
4. |
Future Voting-Related Amendments to the Restated Certificate of
Incorporation May Be Approved by Majority Vote. |
Both Article VII Section 7.05 and Article IX
Section 9.01 of the Restated Certificate of Incorporation
currently require a super-majority vote for any amendment to
Article VII. If this proposal is approved, Article VII
Section 7.05 and Article IX Section 9.01 would be
amended to delete the super-majority vote requirement for future
amendments to Article VII. As a result, if stockholders in
the future wish to reestablish a classified Board, such
reestablishment would need the affirmative vote of only
15
|
|
ZIMMER HOLDINGS, INC. |
2007 PROXY STATEMENT |
a majority of the combined voting power of the then-outstanding
shares of all classes and series of our stock entitled to vote
generally in the election of directors at a meeting at which a
quorum is present.
Appendix B to this proxy statement shows the relevant
portions of Articles VII and IX of the Restated Certificate
of Incorporation as proposed to be amended in connection with
this proposal. If approved, the proposal will become effective
upon the filing of a Certificate of Amendment to the Restated
Certificate of Incorporation with the Secretary of State of the
State of Delaware. If the proposal is approved by the required
super-majority vote, we would make such a filing promptly after
the annual meeting.
THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT
STOCKHOLDERS VOTE FOR APPROVAL OF THE PROPOSED
AMENDMENTS TO THE RESTATED CERTIFICATE OF INCORPORATION TO
REQUIRE THE ANNUAL ELECTION OF ALL DIRECTORS.
PROPOSAL 4. ADOPT SIMPLE MAJORITY VOTE
Mr. John Chevedden, as legal proxy for Victor Rossi, who
holds 400 shares of our common stock, has informed us that
he intends to submit the following proposal at this years
meeting:
|
|
|
|
RESOLVED: Shareholders recommend that our Board take each step
necessary to adopt a
simple majority vote to apply to the greatest extent possible. |
|
|
|
This proposal is not intended to unnecessarily limit our
Boards judgment in crafting the
requested change to the fullest extent feasible in accordance
with applicable laws and existing
governance documents. |
|
|
|
Victor Rossi, P.O. Box 249, Boonville, Calif. 95415
sponsors this proposal. |
|
|
|
This topic won a 66% yes-vote average at 20 major companies in
2006. The Council of
Institutional Investors www.cli.org formally recommends
adoption of this proposal topic. |
|
|
|
Our current rule allows a small minority to frustrate the will
of our shareholder majority. For
example, in requiring an 80%-vote on a number of key governance
issues, if our vote is an
overwhelming 79%-yes and only 1%-no only 1% could
force their will on our 79%-majority. |
|
|
|
When one considers abstentions and broker non-votes, a
supermajority vote can be almost
impossible to obtain. For example, a proposal for annual
election of each director at Goodyear
(GT) failed to pass even though 90% of votes cast were in
favor of the proposal. While
companies often state that the purpose of supermajority
requirements is to provide companies
with the ability to protect minority shareholders,
supermajority requirements are arguable most
often used to block initiatives opposed by management but
supported by most shareowners. The
Goodyear Tire & Rubber Company vote is a perfect
illustration. |
|
|
|
Corporate governance procedures and practices, and the level of
accountability they impose, are
arguable closely related to financial performance. It is
intuitive that, when directors are
accountable for their actions, they perform better.
Shareholders are willing to pay a premium for
shares of corporations that have excellent corporate
governance, as illustrated by a recent study
by McKinsey & Co. If our Company were to remove its
supermajority requirements, it would be
a strong statement that our Company is committed to good
corporate governance and its long-
term financial performance. |
|
Adopt Simple Majority Vote
Yes on 4
Statement in Opposition
The Board of Directors unanimously recommends a vote
AGAINST adoption of this stockholder proposal for
the following reasons:
The Board of Directors is firmly committed both to ensuring
effective corporate governance and maximizing stockholder value.
We are very proud of our governance practices that have
supported the companys ability to be named to the
Forbes Platinum 400 list of the Best Big Companies
in America for the third straight year and to rank first
among its largest competitors in five-year total stockholder
return. We have demonstrated our commitment to following best
practices in corporate governance by our policies with respect
to stockholder rights plans and auditor ratification, as well as
our recent
16
|
|
ZIMMER HOLDINGS, INC. |
2007 PROXY STATEMENT |
actions to adopt majority voting in director elections and
support managements proposal to require the annual
election of all directors. In addition, highly respected
third-party governance research firms have found our governance
practices to be exemplary. As of February 23, 2007,
Institutional Shareholder Services rated Zimmer as outperforming
97.5% of the companies in the S&P 500 Index and 100% of the
companies in the Health Care Equipment & Services
industry group. GovernanceMetrics
International®
rated Zimmer 8.5 out of 10 in its July 2006 rating analysis.
The proposal seeks changes in the companys Restated
Certificate of Incorporation and Restated By-Laws to eliminate
provisions that require an 80% (super-majority) vote
for certain stockholder actions. Unlike some other companies,
Zimmer essentially has only two such provisions in its
organizational documents, which provisions can only be changed
by an 80% affirmative vote:
|
|
|
|
|
an 80% affirmative vote requirement to amend certain provisions
of the Restated Certificate of Incorporation and Restated
By-Laws relating to stockholder action and board of director
matters, and |
|
|
|
an 80% affirmative vote requirement to remove a director from
office. |
As discussed in Proposal 3 beginning on
page , management is proposing
certain amendments to the companys Restated Certificate of
Incorporation which would, in addition to requiring the annual
election of all directors, eliminate the 80% vote requirement to
remove a director from office and eliminate the 80% vote
requirement to amend the provisions of the Restated Certificate
of Incorporation relating to board of director matters.
Accordingly, if stockholders approve Proposal 3 (and after
the company files a Certificate of Amendment to its Restated
Certificate of Incorporation to effectuate the changes), the
only provisions of Zimmers organizational documents
requiring a super-majority vote of stockholders would be the 80%
affirmative vote requirement to amend certain provisions of
those documents relating to stockholder action.
We believe that there are important governance reasons for
retaining the limited super-majority voting provisions in the
companys Restated Certificate of Incorporation and
Restated By-laws, as these provisions help to protect the
interests of stockholders. A reduction in the 80% vote
requirement for these provisions could weaken our ability, as an
independent Board, to preserve and maximize value for all
stockholders in an unsolicited or hostile attempt to
acquire control of the company. The 80% vote requirement of
these provisions would not preclude a takeover offer. However,
the provisions serve in part to encourage potential acquirers to
negotiate with the Board rather than just a few large
stockholders whose interests might diverge from those of the
other stockholders. Thus, they help the Board ensure that all
stockholders are treated fairly.
Further, the super-majority voting requirements do not preclude
changes to Zimmers Restated Certificate of Incorporation
or Restated By-Laws. Rather, they help to ensure that certain
fundamental changes to the companys organizational
documents are made only with a broad consensus of stockholders,
rather than by a simple majority of stockholders
(which may, in practice, be as little as 25.1% of shares
outstanding).
After careful consideration of the proposal, the Board of
Directors believes that eliminating these limited
super-majority voting provisions in the
companys Restated Certificate of Incorporation and
Restated By-Laws would not be in the best interests of the
company and its stockholders. Therefore, we recommend a vote
against the proposal.
THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT YOU VOTE
AGAINST THE ADOPTION OF THIS STOCKHOLDER PROPOSAL.
PROXIES SOLICITED BY THE BOARD OF DIRECTORS WILL BE SO VOTED
UNLESS STOCKHOLDERS SPECIFY OTHERWISE IN THEIR PROXIES.
17
|
|
ZIMMER HOLDINGS, INC. |
2007 PROXY STATEMENT |
2008 PROXY PROPOSALS
To be considered for inclusion in next years proxy
statement, we must receive stockholder proposals relating to the
2008 annual meeting of stockholders at our principal executive
offices, 345 East Main Street, Warsaw, Indiana 46580, Attention:
Corporate Secretary, no later than November 23, 2007.
Under our Restated By-Laws, as amended, no business may be
brought before an annual meeting except as set forth in the
notice of the meeting or as otherwise brought before the meeting
by or at the direction of the Chairman of the Board or by a
stockholder entitled to vote who has delivered notice to us
containing certain information set forth in the Restated
By-Laws, as amended, not later than the 90th day nor
earlier than the 120th day prior to the first anniversary
of the preceding years annual meeting. For our meeting in
2008, we must receive this notice no later than February 7,
2008 and no earlier than January 8, 2008. However, in the
event that the 2008 annual meeting is called for a date that is
more than 30 days before or more than 60 days after
May 7, 2008, notice must be delivered no earlier than the
120th day prior to the 2008 annual meeting and not later
than the later of the 90th day prior to the 2008 annual
meeting or the 10th day following the day public
announcement of the date of the meeting is first made. These
notice requirements are deemed satisfied by a stockholder who
has complied with SEC
Rule 14a-8 and
whose proposal is included in our proxy statement. A copy of the
by-law provisions discussed above may be obtained by writing us
at our principal executive offices, 345 East Main Street,
Warsaw, Indiana 46580, Attention: Corporate Secretary.
INCORPORATION BY REFERENCE
The sections of this proxy statement entitled Audit
Committee Report and Compensation Committee
Report do not constitute soliciting material and should
not be deemed filed or incorporated by reference into any other
filing under the Securities Act of 1933, as amended, or the
Exchange Act, except to the extent we specifically incorporate
them by reference therein.
18
|
|
ZIMMER HOLDINGS, INC. |
2007 PROXY STATEMENT |
Appendix A
ZIMMER HOLDINGS, INC.
CATEGORICAL STANDARDS OF DIRECTOR INDEPENDENCE
As permitted by the rules of the New York Stock Exchange, the
Board has adopted categorical standards to assist it in making
determinations of independence. These standards incorporate, and
are consistent with, the definition of independent
contained in the New York Stock Exchange listing rules. Any
determination of independence for a director who does not meet
these standards will be specifically explained in the
Companys proxy statement. The standards are as follows:
|
|
A. |
A director will not be independent if, within the preceding
three years: |
|
|
|
|
1. |
the director was employed by the Company; |
|
|
2. |
an immediate family member of the director was employed by the
Company as an executive officer; |
|
|
3. |
the director, or an immediate family member of the director,
received more than $100,000 during any twelve-month period in
direct compensation from the Company, other than director and
Board committee fees or deferred compensation for prior service; |
|
|
4. |
the director was (but is no longer) a partner or employee of the
Companys internal or external auditor and personally
worked on the Companys audit within that time or is a
current partner or employee of such firm; |
|
|
5. |
an immediate family member of the director was (but is no
longer) a partner or employee of the Companys internal or
external auditor and personally worked on the Companys
audit within that time or is a current employee of such firm and
participates in the firms audit, assurance or tax
compliance practice or is a current partner of the firm; |
|
|
6. |
an executive officer of the Company was on the compensation
committee of the board of directors of a company that
concurrently employed the director or employed an immediate
family member of the director as an executive officer; or |
|
|
7. |
a company made payments to or received payments from the Company
for property or services in an amount which, in any single
fiscal year, exceeded the greater of $1 million or 2% of
such other companys consolidated gross revenues, and such
company currently employs the director or currently employs an
immediate family member of the director as an executive officer. |
|
|
B. |
A director will not be independent if: |
|
|
|
|
1. |
the director is employed as an executive officer of a company
that is indebted to the Company, or to which the Company is
indebted, and the total amount of either companys
indebtedness to the other is more than 5% of the total
consolidated assets of the company that employs the director; |
|
|
2. |
the Company owns or controls more than 5% of the outstanding
equity interests of a company that employs the director as an
executive officer; or |
|
|
3. |
the director serves as an officer, director or trustee of a
charitable organization, and the Companys discretionary
charitable contributions to the organization are more than 5% of
the organizations total annual charitable receipts or more
than 10% of the Companys total annual charitable
contributions. (Any automatic matching of employees
charitable contributions would not be included in the
Companys annual charitable contributions for this purpose). |
|
|
C. |
A director will not be independent for purposes of serving on
the Companys Audit Committee if: |
|
|
|
|
1. |
the director or an immediate family member of the director
accepts any consulting, advisory, or other compensatory fee from
the Company, other than director or Board committee fees or
fixed amounts of compensation under a retirement plan or
deferred compensation plan for prior service; |
|
|
2. |
the director is a partner, member, managing director or
executive officer of, or occupies a similar position with, an
entity which provides accounting, consulting, legal, investment
banking or financial advisory services to the Company; or |
|
|
3. |
the director is an affiliate of the Company apart from the
directors capacity as a member of the Board and any Board
committee. |
A-1
|
|
ZIMMER HOLDINGS, INC. |
2007 PROXY STATEMENT |
|
|
D. |
For purposes of these director independence standards: |
|
|
|
|
1. |
references to the Company include the Companys
consolidated subsidiaries; |
|
|
2. |
a directors immediate family members include
his or her spouse, parents, children, siblings, mothers and
fathers-in-law, sons
and daughters-in-law,
brothers and
sisters-in-law and
anyone (other than domestic employees) who shares the
directors home; and |
|
|
3. |
an affiliate of the Company is a person that
directly, or indirectly through one or more intermediaries,
controls, is controlled by, or is under common control with, the
Company. |
A-2
|
|
ZIMMER HOLDINGS, INC. |
2007 PROXY STATEMENT |
Appendix B
ZIMMER HOLDINGS, INC.
RELEVANT PORTIONS OF ARTICLES VII AND IX OF
THE RESTATED CERTIFICATE OF INCORPORATION
(As Proposed to Be Amended May 7, 2007)
ARTICLE VII
BOARD OF DIRECTORS
SECTION 7.01. NUMBER, ELECTION
AND TERMS. Except as otherwise fixed by or pursuant to the
provisions of Article IV hereof relating to the rights of
the holders of any class or series of stock having a preference
over the Common Stock as to dividends or upon liquidation,
dissolution or winding up to elect additional Directors under
specified circumstances, the number of the Directors shall be
fixed from time to time exclusively pursuant to a resolution
adopted by a majority of the Whole Board (but shall not be less
than three). Beginning with the 2008 annual meeting of
stockholders, the Directors whose terms are expiring, other than
those who may be elected by the holders of any class or series
of stock having a preference over the Common Stock as to
dividends or upon liquidation, dissolution or winding up, shall
be elected for one-year terms, with each Director to hold office
until such persons successor is duly elected and qualified.
SECTION 7.03. NEWLY CREATED
DIRECTORSHIPS AND VACANCIES. Except as otherwise provided
for or fixed by or pursuant to the provisions of Article IV
hereof relating to the rights of the holders of any class or
series of stock having a preference over the Common Stock as to
dividends or upon liquidation, dissolution or winding up to
elect Directors under specified circumstances, newly created
directorships resulting from any increase in the number of
Directors and any vacancies on the Board of Directors resulting
from death, resignation, disqualification, removal or other
cause shall only be filled by the affirmative vote of a majority
of the remaining Directors then in office, even though less than
a quorum of the Board of Directors, and not by the stockholders.
Any Director elected in accordance with the preceding sentence
shall serve a term expiring at the next annual meeting of
stockholders and until such Directors successor shall have
been duly elected and qualified. No decrease in the number of
Directors constituting the Board of Directors shall shorten the
term of any incumbent Director.
SECTION 7.04. REMOVAL.
Subject to the rights of any class or series of stock having a
preference over the Common Stock as to dividends or upon
liquidation, dissolution or winding up to elect Directors under
specified circumstances, any Director may be removed from office
with or without cause and only by the affirmative vote of the
holders of at least a majority of the voting power of all Voting
Stock then outstanding, voting together as a single class.
SECTION 7.05. AMENDMENT, REPEAL,
ETC. Notwithstanding anything contained in this Restated
Certificate of Incorporation to the contrary, the affirmative
vote of the holders of at least a majority of the voting power
of all Voting Stock then outstanding, voting together as a
single class, shall be required to alter, amend, adopt any
provision inconsistent with or repeal this Article VII.
ARTICLE IX
AMENDMENT OF CERTIFICATE OF INCORPORATION
SECTION 9.01. The Corporation reserves the right at
any time from time to time to amend, alter, change or repeal any
provision contained in this Restated Certificate of
Incorporation, and any other provisions authorized by the laws
of the State of Delaware at the time in force may be added or
inserted, in the manner now or hereafter prescribed by law; and,
except as set forth in Article X, all rights, preferences
and privileges of whatsoever nature conferred upon stockholders,
Directors or any other persons whomsoever by and pursuant to
this Restated Certificate of Incorporation in its present form
or as hereafter amended are granted subject to the right
reserved in this Article.
Notwithstanding anything contained in this Restated Certificate
of Incorporation to the contrary, the affirmative vote of the
holders of at least 80% of the Voting Stock then outstanding,
voting together as a single class, shall be required to alter,
amend, adopt any provision inconsistent with or repeal
Article V, VIII or this sentence.
B-1
ZIMMER HOLDINGS, INC.
C/O THE BANK OF NEW YORK
101 BARCLAY STREET, 11TH FLOOR EAST
NEW YORK, NY 10286
VOTE BY INTERNET www.proxyvote.com
Use the Internet to transmit your voting
instructions and for electronic delivery of
information up until 11:59 P.M. Eastern Time on May
6, 2007 (or May 2, 2007 for shares held in the
companys Savings and Investment Programs). Have
your proxy card in hand when you access the web
site and follow the instructions to obtain your
records and to create an electronic voting
instruction form.
ELECTRONIC DELIVERY OF FUTURE SHAREHOLDER COMMUNICATIONS
If you would like to reduce the costs incurred by
Zimmer Holdings, Inc. in mailing proxy materials,
you can consent to receiving all future proxy
statements, proxy cards and annual reports
electronically via e-mail or the Internet. To sign
up for electronic delivery, please follow the
instructions above to vote using the Internet and,
when prompted, indicate that you agree to receive
or access shareholder communications electronically
in future years.
VOTE BY PHONE 1-800-690-6903
Use any touch-tone telephone to transmit your
voting instructions up until 11:59 P.M. Eastern
Time on May 6, 2007 (or May 2, 2007 for shares held
in the companys Savings and Investment Programs).
Have your proxy card in hand when you call and then
follow the instructions.
VOTE BY MAIL
Mark, sign and date your proxy card and return it
in the postage-paid envelope we have provided or
return it to Zimmer Holdings, Inc., c/o ADP, 51
Mercedes Way, Edgewood, NY 11717.
|
|
|
|
|
|
|
|
|
TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: |
|
|
ZIMER1 |
|
|
KEEP THIS PORTION FOR YOUR RECORDS |
|
|
|
|
|
|
|
DETACH AND RETURN THIS PORTION ONLY |
THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.
ZIMMER HOLDINGS, INC.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR PROPOSALS 1, 2 & 3 AND AGAINST PROPOSAL 4.
|
|
|
|
|
|
|
|
|
|
|
|
|
1. |
|
Election of Directors: |
|
BOARD RECOMMENDS |
|
For |
|
Against |
|
Abstain |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.
|
|
Larry C. Glasscock
|
|
FOR
|
|
o
|
|
o
|
|
o |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.
|
|
John L. McGoldrick
|
|
FOR
|
|
o
|
|
o
|
|
o |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
|
Auditor Ratification |
|
FOR |
|
o |
|
o |
|
o |
|
|
|
|
|
|
|
|
|
|
|
|
|
3. |
|
Amendment of Restated Certificate of Incorporation to Require Annual Election of All Directors |
|
FOR |
|
o |
|
o |
|
o |
|
|
|
|
|
|
|
|
|
|
|
|
|
4. |
|
Stockholder Proposal to Adopt Simple Majority Vote |
|
AGAINST |
|
o |
|
o |
|
o |
For address changes and/or comments, please check this box o
and write them on the back where indicated.
NOTE: Please sign as name appears hereon.
Joint owners should each sign. When
signing as attorney, executor,
administrator, trustee or guardian,
please give full title as such.
The shares represented by this proxy will
be voted as directed by the stockholder.
Where no direction is given when the duly
executed proxy is voted, such shares will
be voted FOR Items 1, 2 & 3 and AGAINST
Item 4.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Signature [PLEASE SIGN WITHIN BOX] |
|
|
Date |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Signature (Joint Owners) |
|
|
Date |
|
ZIMMER HOLDINGS, INC.
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
The undersigned hereby appoints J. Raymond Elliott, Sam R. Leno, David C. Dvorak and Chad
F. Phipps, and each of them, proxies, with full power of substitution in each of them, for and on
behalf of the undersigned to vote as proxies, as directed and permitted herein, at the Annual
Meeting of Stockholders of the company to be held at The New York Palace Hotel, 455 Madison
Avenue, New York, New York on Monday, May 7, 2007, at 9:00 a.m., and at any adjournments thereof
upon matters set forth in the Proxy Statement and, in their judgment and discretion, upon such
other business as may properly come before the meeting.
ANNUAL MEETING OF STOCKHOLDERS MAY 7, 2007
When properly executed, your proxy will be voted as you indicate, or where no contrary
indication is made, will be voted FOR Proposals 1, 2 and 3 and AGAINST Proposal 4. The full text of
the proposals and position of the Board of Directors on each appears in the Proxy Statement and
should be reviewed prior to voting.
IMPORTANT: YOUR VOTE IS IMPORTANT. PLEASE VOTE THESE SHARES TODAY.
For participants in the Zimmer Holdings, Inc. Savings and Investment Program or the Zimmer
Puerto Rico Savings and Investment Program.
The Trustee will vote the shares credited to this account in accordance with the specifications
that you indicate on the reverse. If you sign and return the form, but do not indicate your voting
specifications, the Trustee will vote as recommended by the Board of Directors. Unless otherwise
instructed prior to May 2, 2007, the Trustee WILL VOTE these shares in the same manner and
proportion as the shares for which the Trustee received voting specifications. The Trustee will
exercise its discretion in voting on any other matter that may be presented for a vote at the
meeting and at adjournments or postponements.
Continued on the reverse side.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Address Changes/Comments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(If you noted any Address Changes/Comments above, please mark corresponding box on the reverse side.)